Listed by the USPTO as SAEED, KAMAL A
Tech Center 1600 • Art Units: 1623 1626
This examiner grants 84% of resolved cases
SAEED, KAMAL A is assigned to tech center 1600 and art unit 1623. The docket includes 1217 resolved cases, with an 83.8% allowance rate and a 9.8% interview lift. The median time to allowance is 761 days. The extensive record and favorable allowance outcome provide a useful basis for prosecution planning.
Boehringer Ingelheim International GmbH, Novo Nordisk A/S, and BAE Systems plc are the leading companies. FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, FOLEY HOAG, LLP (General), and BALLARD SPAHR LLP are the leading firms. The modest interview lift suggests that applicants should emphasize precise written responses while reserving interviews for targeted issues.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18872318 | HSD17B13 INHIBITORS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18847898 | A METHOD OF PRODUCING EXPLOSIVE HMX BY FLOW SYNETHESIS | Non-Final OA | BAE SYSTEMS PLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy83.8% of resolved applications examined by Kamal A Saeed were allowed (1,217 resolved cases), compared with 51.3% across Art Unit 1623 over the last five years.
This examiner's interview lift is +9.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kamal A Saeed took 761 days on average from filing to allowance.
Kamal A Saeed examines applications in Art Unit 1623 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
